#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Giant cell tumour of tendon sheath Guillain-Barre syndrome Retinal artery occlusion Huntington's disease Chronic myeloid leukaemia Graft versus host disease Friedreich's ataxia Sexually transmitted disease Cardiac sarcoidosis Neurofibromatosis Adenoid cystic carcinoma Cystic fibrosis lung Anal fistula Hodgkin's disease Human papilloma virus immunisation More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Diagnostics Aicardi-Goutieres syndrome – Trials in Disease Loeys-Dietz syndrome – Trials in Disease Leiomyosarcoma metastatic – Diagnostics Adrenocortical carcinoma Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Langerhans cell sarcoma – Trials in Disease Soft tissue sarcoma – Life with Disease Burkitt’s lymphoma – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VOXVOGANAN Pal1-15 Acetate Evencaleucel Atezolizumab Ethinylestradiol Cetrelimab Timothy Grass Pollen Extract Vb10.16 Chlortalidone SOFOSBUVIR Octreotide Hydrochloride Iobitridol Tildrakizumab VGA039 Diclofenac Sufentanil EGANELISIB TROFOLASTAT Anthoxanthum Odoratum Ropivacaine More therapies…

    Learn about Your Condition

    Head and neck cancer stage IV CADASIL Aplastic anaemia Extraskeletal ossification Trisomy 21 Meniscus injury Basal cell carcinoma Hypertriglyceridaemia Lichen sclerosus Thrombosis Lip and/or oral cavity cancer Osteosarcoma recurrent Ocular hypertension Crohn's disease Abdominal pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the safety of MRM-3379 in men with Fragile X Syndrome

    Not yet recruiting

    2 1
    Spain

  • A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    France

  • A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • ZAMPILIMAB
    Belgium Bulgaria Czechia France Germany Italy +5

  • A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Low anterior resection syndrome
    Investigated Drugs:
    • ISPAGHULA HUSK
    Norway

  • Study of dexmedetomidine and a drug combination for treating patients on mechanical ventilation with septic shock.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Hydrocortisone Acetate
    • Noradrenaline Tartrate
    France

  • A study of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Spain
Previous Page
1 … 717 718 719 720 721 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!